Povidone Iodine Price Trend and Forecast 2026-2027

Key Takeaways

• Global povidone iodine prices eased through 2025, with the global average slipping from USD 17.32/KG in Q1 to USD 15.48/KG by Q4 and USD 15.30/KG in Q1 2026, as softer povidone feedstock costs offset still-elevated iodine values.
• Prices fell hardest early, with a drop of close to 8 percent in Q2 2025, before the decline slowed to a gentle drift through the rest of the period.
• India, the market tracked here, traded in a USD 15.30 to 17.32/KG band including early 2026, supported by a large generic pharmaceutical base and proximity to Asian povidone and iodine supply.
• The market stayed broadly steady because two inputs pulled in opposite directions: povidone polymer softened on oversupply, while iodine remained historically expensive, leaving the finished complex little net movement.
• The povidone iodine market forecast for the rest of 2026 leans broadly stable, with steady antiseptic, surgical, and wound-care demand setting a floor while soft povidone costs cap the upside.

What Is Povidone Iodine and Why Does It Matter?

Povidone iodine, also written as PVP-I, is a stable chemical complex of iodine with the water-soluble polymer povidone, or polyvinylpyrrolidone. The polymer essentially acts as a carrier that eventually releases iodine, giving the complex broad antimicrobial activity with really less irritation and also staining than free iodine. It is made by combining povidone with iodine under controlled conditions, so its cost base traces to two inputs.

From a market view, povidone iodine is a workhorse antiseptic rather than a bulk chemical. It sits on the World Health Organization list of essential medicines and is used across surgical preparation, wound care, and disinfection worldwide. Demand is defensive and healthcare-led, which gives it a steady volume profile, while pricing reflects the tug-of-war between a soft povidone market and a firm iodine market. Production capacity is concentrated among specialty pharmaceutical-ingredient makers in Asia, Europe, and North America.

Which Sectors Are Driving Povidone Iodine Demand?

• Topical Antiseptics and Skin Disinfection: the largest end-use. Povidone iodine is the standard for pre-operative skin preparation, surgical scrubs, and general skin disinfection, which anchors a steady, healthcare-led demand base.
• Surgical and Hospital Use: surgical site preparation, instrument and surface disinfection, and infection control across hospitals make this a core, volume-stable segment.
• Wound Care and Over-the-Counter: ointments, solutions, gargles, and first-aid products bring povidone iodine into consumer and pharmacy channels, a resilient retail outlet.
• Veterinary: animal wound care and udder dips in dairy farming provide a meaningful secondary demand pool tied to livestock production.
• Other Specialty Uses: preservative and select industrial and cosmetic applications round out the demand base, a small but stable tail.

Global Povidone Iodine Price Trend in 2025

Global povidone iodine prices eased through 2025. The key dynamic was a split in its two inputs: povidone polymer softened on oversupply and weak broader demand, while iodine stayed historically elevated even after coming off its peak. The net effect was a steady drift lower, with the global quarterly average slipping from USD 17.32/KG in Q1 to USD 15.48/KG by Q4, a fall of around 11 percent.

Q1 2026 eased to USD 15.30/KG, suggesting the market was still searching for a floor as the two opposing input forces played out. Because demand is healthcare-led and defensive, volumes stayed steady throughout, so the decline reflected input costs rather than any weakening in underlying consumption.

What Were India’s Povidone Iodine Price Trends in 2025?

India is a major producer and consumer of povidone iodine, supported by its large generic pharmaceutical industry and proximity to Asian povidone and iodine supply. Prices here track Asian input costs plus a modest premium, and the country’s scale in finished antiseptic products gives Indian buyers strong negotiating weight.

Indian prices eased from USD 17.32/KG in Q1 2025 to USD 15.48/KG by Q4, then USD 15.30/KG in Q1 2026 as povidone costs softened. Domestic formulators serving hospital, retail, and export markets bought on steady schedules, so the decline reflected cheaper polymer rather than any demand shift.

What Factors Drove Povidone Iodine Costs in 2025?

• Povidone polymer costs. The carrier polymer softened on oversupply and weak broader demand through 2025, which was the main downward pull on the finished complex.
• Iodine prices. Iodine stayed historically elevated even after easing from its peak, keeping a firm floor under the complex and offsetting the softer polymer cost.
• Defensive healthcare demand. As an essential antiseptic used across surgery, wound care, and disinfection, demand held steady, so volumes did not amplify the price move.
• Quality and regulatory specifications. Pharmaceutical-grade material commands a premium and limits substitution, especially in Europe and North America where documentation requirements are strict.
• Concentrated specialty supply. Production sits with a limited number of pharmaceutical-ingredient makers, which lends the market pricing discipline and kept the decline orderly.
• Currency and freight. A soft rupee and a volatile real shaped import economics for India and Brazil, while freight added to landed costs in import-dependent markets.

Povidone Iodine Market Forecast for 2026

The povidone iodine market forecast for the rest of 2026 leans broadly stable. Soft povidone costs and steady-to-easing iodine point to flat pricing, while healthcare-led demand from antiseptic, surgical, and wound-care uses provides a firm floor under volumes regardless of the price path.

The bull case is renewed iodine tightness from its concentrated supply base, which would lift the complex despite soft polymer costs. The bear case is continued povidone oversupply passing through into gently lower prices. Either way, demand is unlikely to move much, because the core use is essential healthcare.

Expected Povidone Iodine Price Range (remainder of 2026)

Europe stays the outlier on the upside on pharmaceutical specifications and demand quality. India holds the low end on its large generic base and Asian supply. North America sits just below Europe, while the whole market stays steady on balanced input costs.

Key Analyst Insights for the Povidone Iodine Market

• Povidone iodine is a two-input balancing act. With povidone soft and iodine firm, the finished complex moves less than either input alone, which steadies the market.
• Demand is defensive. Its place on the essential-medicines list and its use across surgery and wound care give volumes a healthcare floor that holds through cost swings.
• Iodine is the upside risk. Because iodine supply is concentrated in Chile and Japan, any tightening there is the main threat to otherwise stable pricing.
• Pharmaceutical grade is the defensible niche, far less exposed to price competition than technical material and supported by strict documentation and purity requirements.
• India’s scale shapes the global floor. As a large producer and exporter, Indian conversion economics effectively set the low end of the international market.

Key Takeaways for Buyers and Manufacturers

For Buyers

• Buy on steady schedules. With prices flat, there is little reward in heavy forward cover, though watching iodine helps time any opportunistic purchases.
• Track iodine and povidone together. The two inputs move in opposite directions, so monitoring both gives a clearer read on where the finished price is heading.
• Prioritise certified supply for medical use. Documentation and purity matter far more than small price differences in surgical and wound-care applications.
• Diversify origins. Maintaining more than one qualified supplier reduces exposure to iodine-driven disruption or single-source risk.

For Manufacturers

• Iodine sourcing is the key lever. Securing reliable, competitively priced iodine is the biggest single influence on povidone iodine margins.
• Pharmaceutical grade holds value. Medical-grade complex is far less exposed to price competition than technical material.
• Supply continuity is a differentiator. Hospital and surgical buyers value dependable, documented delivery over marginal price.
• Integration into povidone helps. Producers with captive or formula-linked polymer supply smooth one side of the dual-input cost cycle.